News & Events

HIV-1 Inhibitor Designed by LFKRI’s Laboratory of Molecular Modeling & Drug Design Shows Promise in Pre-Clinical Experimental Model

LFKRI’s Dr. Karina Yazdanbakhsh Receives NIH R01 Grant and ASH Bridge Fund Grant for Sickle Cell Disease Study

LFKRI Scientists Identify Key Macrophages that Support Red Cell Development

Frequently Asked Questions About RHD Genotyping

What We’ve Learned About Preventing Hemolytic Disease of the Fetus & Newborn

Rh Typing & The Need for Standardization

What Are the Ethical Implications of Excessive RhIG Usage?

NYBC Now Part of REDS-IV-P Research Program

NIH R21 Grant on Zika Therapeutics Awarded to LFKRI’s Dr. Lanying Du

Which Patients Should be Tested With RHD Genotyping?